<?xml version="1.0" encoding="UTF-8"?>
<funding-group>
 <funding-statement>LO acknowledges funding from the French Government’s “Investissement d’Avenir” program, Laboratoire d’Excellence “Integrative Biology of Emerging Infectious Diseases” (grant no. ANR-10-LABX-62-IBEID), and from Région Île-de-France (Domaine d’Intérêt Majeur Maladies Infectieuses). RME and MB acknowledge funding from the National Institute for Health Research through the Health Protection Research Unit in Immunisation at the London School of Hygiene &amp; Tropical Medicine in partnership with Public Health England. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
